Fred Alger Management, LLC Repare Therapeutics Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$12.5 - $18.13 $53,200 - $77,161
-4,256 Reduced 17.51%
20,055 $295,000
Q3 2022

Nov 14, 2022
BUY
$11.57 - $15.59 $17,806 - $23,993
1,539 Added 6.76%
24,311 $295,000
Q2 2022

Aug 15, 2022
BUY
$8.45 - $14.84 $192,423 - $337,936
22,772 New
22,772 $319,000
Q3 2020

Nov 13, 2020
SELL
$21.55 - $33.92 $840 - $1,322
-39 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$30.8 - $32.99 $1,201 - $1,286
39 New
39 $1,000

Others Institutions Holding RPTX

# of Institutions
62
Shares Held
35.4M
Call Options Held
50K
Put Options Held
300
View Full List

About Repare Therapeutics Inc.

RPTX Quotes by TradingView
  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email